dc.contributor.author | Tural, Deniz | |
dc.contributor.author | Arslan, Çağatay | |
dc.contributor.author | Selçukbiricik, Fatih | |
dc.contributor.author | Ölmez, Ömer Fatih | |
dc.contributor.author | Akar, Emre | |
dc.contributor.author | Erman, Mustafa | |
dc.contributor.author | Ürün, Yüksel | |
dc.contributor.author | Erdem, Dilek | |
dc.contributor.author | Kılıçkap, Saadettin | |
dc.date.accessioned | 2023-12-11T11:27:21Z | |
dc.date.available | 2023-12-11T11:27:21Z | |
dc.date.issued | 2023 | en_US |
dc.identifier.citation | Tural, D., Arslan, Ç., Selçukbiricik, F., Ölmez, Ö. F., Akar, E., Erman, M. ... Kılıçkap, S. (2023). Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma. Genitourinary Cancers Symposium. Electrical Network, 16-18 February, 2023. | en_US |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/11977 | |
dc.description.abstract | ... | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Metastatic Urothelial Carcinoma | en_US |
dc.subject | Checkpoint Inhibitors | en_US |
dc.subject | Long-Term Overall Survival | en_US |
dc.subject | Objective Response | en_US |
dc.title | Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma. | en_US |
dc.type | conferenceObject | en_US |
dc.relation.ispartof | Genitourinary Cancers Symposium | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi | en_US |
dc.identifier.volume | 41 | en_US |
dc.identifier.issue | Supplement: 6 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.identifier.wos | 001098050200510 | en_US |